Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ

Revenue (LTM)

$13M

+29.8% YoY

Net Income (LTM)

$-124M

+4.6% YoY

Free Cash Flow

$-103M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	8	10↑29.9%	13↑29.8%
Gross Profit	0	0	3	2↓23.1%	6↑177.7%
Operating Income	-92	-112↓21.4%	-118↓5.6%	-137↓15.5%	-126↑8.0%
Net Income	-92	-110↓19.4%	-117↓5.8%	-130↓11.5%	-124↑4.6%
EBITDA	-92	-111↓20.1%	-114↓2.9%	-74↑34.9%	-124↓66.5%
EPS Diluted	-163968.00	-811.68↑99.5%	-6368.84↓684.6%	-176.60↑97.2%	-14.57↑91.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	179	120↓32.7%	25↓79.2%	99↑295.9%	208↑110.2%
Total Current Assets	189	131↓30.8%	48↓63.5%	119↑149.1%	229↑92.3%
Total Assets	241	226↓6.3%	154↓31.6%	163↑5.5%	277↑70.2%
Total Current Liabilities	22	18↓16.3%	19↑3.9%	18↓3.1%	31↑68.4%
Total Liabilities	22	19↓16.6%	49↑164.4%	23↓52.3%	32↑37.2%
Total Equity	219	207↓5.3%	106↓49.1%	140↑32.3%	245↑75.7%
Total Debt	1	1↓20.5%	10↑1191.2%	5↓46.0%	1↓75.3%
Net Debt	-178	-119↑32.8%	-15↑87.3%	-93↓517.6%	-206↓120.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-76	-98↓29.8%	-102↓4.0%	-61↑40.3%	-100↓63.9%
Capital Expenditure	-35	-48↓36.4%	-8↑83.6%	-0↑98.5%	-3↓2707.5%
Free Cash Flow	-111	-146↓31.9%	-110↑24.8%	-61↑44.5%	-103↓69.1%
Stock-Based Comp	8	11↑38.2%	9↓15.0%	5↓48.5%	6↑25.9%
Net Change in Cash	102	-58↓157.5%	-95↓61.9%	74↑178.0%	109↑47.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance